Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company

SAN DIEGO, July 17, 2015 /PRNewswire/ — Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and its associated pain, announced today that Mr. George Uy, Executive Vice President and Chief Commercial Officer, will be leaving the Company at the end of July 2015 to join a start-up […]

Read More »

Biogen R&D Head Jumps Ship to Helm Unnamed Startup

July 10, 2015By Riley McDermid, Breaking News Sr. Editor Another major biotech executive has jumped shipped to join an unnamed startup, after Biogen, Inc. said Friday that Douglas Williams, head of the company’s Research and Development unit, will leave at the end of July. Williams is leaving to become “the first member of a […]

Read More »

Baxalta Appoints Two New Directors To The Board, Further Diversifying With Strong Biopharmaceutical Leadership Experience

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, announces the appointment of two new board members. Joining the company’s Board of Directors effective July 27, 2015, are Karen Ferrante, M.D., and Francois Nader, M.D., expanding the Board from seven to […]

Read More »

Intouch Solutions Promotes Multiple Chicago Employees

Intouch Solutions proudly announces the promotion of nine employees in its Chicago office. A leading marketing agency serving the pharmaceutical industry, Intouch Solutions has seen rapid expansion over the past five years and actively promotes within the 650-person firm. The nine employees include: Elissa Bernstein, account manager, has proven herself invaluable to the Intouch team […]

Read More »

Precision for Value Adds Prominent Health Economist Dr. Christopher Blanchette to its Expanding HEOR Team

NEW YORK, July 8, 2015 – Precision for Value (, a Precision for Medicine Company which provides health economics, analytics, and marketing communications services to life sciences clients, today announced the further expansion of its Health Economics and Outcomes Research (HEOR) team to meet growing customer demand. Christopher Blanchette, PhD, was appointed Vice President, Health […]

Read More »

HCB Health Names Greg Niemczyk Vice President, Account Director/Business Development of Chicago Office

Healthcare agency veteran brings professional and patient therapeutic expertise and new business development experience to growing independent agency AUSTIN, Texas, July 6, 2015 – HCB Health, one of the nation’s top 25 independent healthcare advertising agencies, announced today that Greg Niemczyk has joined the agency as a vice president, account director/business development. Niemczyk will be […]

Read More »

Joseph J. Echevarria Elected To Pfizer’s Board Of Directors

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. today announced the election of Joseph J. Echevarria to its Board of Directors, effective immediately. Mr. Echevarria also was appointed to the Audit, Regulatory and Compliance and Science and Technology Committees of Pfizer’s Board. Mr. Echevarria, 58, retired as Chief Executive Officer (CEO) of Deloitte LLP, a global provider of professional […]

Read More »

Eleven Biotherapeutics Announces Executive Change

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Gregory D. Perry has resigned as Chief Financial and Business Officer, effective July 3, 2015. John J. McCabe, Eleven’s Vice President of Finance and Business Operations, is promoted to assume […]

Read More »

Leadership Evolution at Ogilvy CommonHealth Worldwide’s New Jersey-Based Specialty and Payer Agencies

PARSIPPANY, NJ–(Marketwired – Jun 24, 2015) – Ogilvy CommonHealth Worldwide (, the health behavior change specialists of Ogilvy & Mather (, and a WPP company (NASDAQ: WPPGY) (, today announced two executive-level changes within management at the organization’s headquarters in Parsippany — with the appointment of Michael Zilligen as president of both Ogilvy CommonHealth Payer […]

Read More »

AstraZeneca loses second top executive as Vectura gets new CEO

AstraZeneca has lost a second senior executive in a fortnight with the departure of its respiratory and inflammatory medicines head James Ward-Lilley to become chief executive of lung drug specialist Vectura. His departure follows the exit earlier this month of Briggs Morrison, AstraZeneca’s former chief medical officer and head of late-stage drug development, who moved […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom